Table 4. Portion of abnormal coagulation test results including thromboelastography based on the reference range suggested in this study.
| Coagulation test | Result | Non-cirrhotic group (N = 52) | Cirrhotic group (N = 123) |
|---|---|---|---|
| PT(INR) | Prolonged, N (%) | 4 (7.7) | 93 (75.6) |
| Platelet (× 109/L) | Decreased, N (%) | 7 (13.5) | 78 (59.1) |
| Increased, N (%) | 0 (0) | 1 (0.8) | |
| Thromboelastography parameter | R (min) | ||
| Prolonged, N (%) | 2 (3.8) | 23 (18.7) | |
| Shortened, N (%) | 1 (1.9) | 3 (2.4) | |
| K (min) | |||
| Prolonged, N (%) | 3 (5.8) | 25 (20.3) | |
| Shortened, N (%) | 0 (0) | 2 (1.6) | |
| α (degree) | |||
| Decreased, N (%) | 3 (5.8) | 17 (13.8) | |
| Increased, N (%) | 0 (0) | 2 (1.6) | |
| MA (mm) | |||
| Decreased, N (%) | 6 (11.5) | 40 (32.5) | |
| Increased, N (%) | 0 (0) | 2 (1.6) | |
| CI | |||
| Negative value, N (%) | 5 (9.6) | 36 (29.3) | |
| Positive value, N (%) | 0 (0) | 2 (1.6) | |
| Presence of any abnormal parameter, N (%) | 9 (17.3) | 55 (44.7) | |
| Presence of any hypocoagulable parameter, N (%) | 8 (15.4) | 52 (42.3) | |
| Presence of any hypercoagulable parameter, N (%) | 1 (1.9) | 3 (2.4) |
Abbreviations: see Table 2.